Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 19, 2022

BUY
$242.49 - $301.46 $114,455 - $142,289
472 Added 16.99%
3,250 $798,000
Q2 2022

Jul 13, 2022

BUY
$224.73 - $338.64 $5,842 - $8,804
26 Added 0.94%
2,778 $688,000
Q1 2022

Apr 19, 2022

BUY
$277.25 - $366.29 $6,931 - $9,157
25 Added 0.92%
2,752 $912,000
Q4 2021

Jan 20, 2022

SELL
$300.63 - $371.35 $6,012 - $7,427
-20 Reduced 0.73%
2,727 $979,000
Q3 2021

Oct 15, 2021

SELL
$310.19 - $376.2 $6,203 - $7,524
-20 Reduced 0.72%
2,747 $894,000
Q4 2020

Feb 02, 2021

SELL
$251.88 - $324.2 $3,022 - $3,890
-12 Reduced 0.43%
2,767 $897,000
Q3 2020

Oct 29, 2020

BUY
$255.22 - $317.0 $9,953 - $12,363
39 Added 1.42%
2,779 $769,000
Q2 2020

Aug 12, 2020

BUY
$141.4 - $257.09 $5,090 - $9,255
36 Added 1.33%
2,740 $661,000
Q1 2020

Apr 21, 2020

SELL
$130.51 - $196.01 $7,569 - $11,368
-58 Reduced 2.1%
2,704 $392,000
Q4 2019

Jan 24, 2020

SELL
$159.31 - $223.54 $2,389 - $3,353
-15 Reduced 0.54%
2,762 $471,000
Q3 2019

Oct 16, 2019

BUY
$175.89 - $279.23 $78,974 - $125,374
449 Added 19.29%
2,777 $494,000
Q2 2019

Aug 13, 2019

SELL
$250.96 - $284.94 $2.69 Million - $3.06 Million
-10,733 Reduced 82.18%
2,328 $606,000
Q1 2019

May 07, 2019

SELL
$276.39 - $362.25 $280,535 - $367,683
-1,015 Reduced 7.21%
13,061 $3.73 Million
Q4 2018

Jan 25, 2019

SELL
$281.08 - $444.25 $343,198 - $542,429
-1,221 Reduced 7.98%
14,076 $4.58 Million
Q3 2018

Oct 15, 2018

SELL
$354.53 - $449.75 $1.34 Million - $1.71 Million
-3,792 Reduced 19.86%
15,297 $6.88 Million
Q2 2018

Jul 31, 2018

SELL
$278.07 - $446.21 $647,346 - $1.04 Million
-2,328 Reduced 10.87%
19,089 $7.81 Million
Q1 2018

Apr 25, 2018

BUY
$192.49 - $295.85 $5,582 - $8,579
29 Added 0.14%
21,417 $6.23 Million
Q4 2017

Jan 25, 2018

BUY
$168.78 - $199.74 $3.61 Million - $4.27 Million
21,388
21,388 $4.01 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.